May 28
23andMe announced that the Online Trust Alliance (OTA) honored 23andMe for protection, security, and the privacy of customer data. 23andMe was named to the OTA Honor Roll overall, and ranked #1 in the Healthcare category. In addition to ranking at the top among Healthcare companies and organizations, 23andMe was ranked in the top 50 of all ...
May 21
23andMe announced that 23andMe Health + Ancestry Service customers can access a new Health Community page focused on hypertrophic cardiomyopathy (HCM), the most common form of inherited heart disease. The new HCM Health Community page offers customers information and resources on this condition, which in most cases is caused by geneti...
Apr 18
23andMe added a new Genetic Health Risk report on TTR-related hereditary amyloidosis. It is a genetic, multi-system disease. Transthyretin amyloidosis is a slowly progressive condition characterized by the buildup of abnormal deposits of a protein called amyloid (amyloidosis) in the body's organs and tissues. These protein deposits most fre...
Apr 11
23andMe is testing an extensive update to their Ancestry Composition feature that dramatically improved results for 23andMe customers with Central and South Asian ancestry. More specifically, this update will benefit those with ancestry from Afghanistan, Pakistan, India, Bangladesh, Sri Lanka, or Nepal. The new ancestry breakdown in Central and ...
Mar 26
23andMe has a new Type 2 Diabetes report that offers customers insight into their likelihood of developing one of the most prevalent, pernicious, and preventable health conditions in the United States. 23andMe hopes that the Type 2 Diabetes report will help raise awareness about diabetes, as well as the potential to make healthy lifestyle changes ...
Feb 14
The Editorial Board of The New York Times posted an opinion piece titled: “Why You Should Be Careful About 23andMe's Health Test”. In response, 23andMe posted a letter to the editor titled: “23andMe Responds: Empowering Consumers”. The two disagree about the accuracy of 23andMe's genetic tests results. The New York Times Editorial Board...
Feb 5
23andMe posted an informative blog that explains why diversity matters in research. Improving diversity and inclusion of underrepresented populations in research doesn't just benefit those groups. It benefits everyone. Africans and African Americans are among the most underrepresented populations in genetic health research, yet they face the mos...
Dec 5
23andMe has put in effort toward improving diversity in its genetic research. This includes their Global Genetics Project and their Populations Collaborations Program. The goal is not only to help diversify 23andMe's research database, but also to drive inclusion of understudied populations. 23andMe points out that currently, more than 90 percen...
Oct 11
October is Breast Cancer Awareness Month. Certain types of breast cancer can run in families. 23andMe offers the first and only FDA-authorized, direct-to-consumer BRCA genetic health risk report. This test focuses on three specific variants of the BRCA1 and BRCA2 genes. 23andMe offers a genetic test for three variants of the BRCA1 and BRCA2 gen...
Jul 9
23andMe announced that they have added four new trait reports to its growing list of more than two-dozen trait reports. The new trait reports are the latest in a series of new offerings for 23andMe customers interested in exploring their genetics in a fun way. 23andMe points out that results from 23andMe research are preliminary and are meant fo...